Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2024

Open Access 01-12-2024 | Furosemide | Case report

Guyton perspective in managing peripartum cardiomyopathy patient with pulmonary edema: a case report

Authors: Ruth Evlin Margaretha, Yohanes W. H. George, Jefferson Hidayat

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Peripartum cardiomyopathy (PPCM) is a potentially life-threatening pregnancy-related condition characterized by left ventricular dysfunction and heart failure, typically occurring in the peripartum period. Individuals with a history of preeclampsia and hypertension are particularly prone to developing PPCM. Recent research suggests that the condition may be triggered by vascular dysfunction influenced by maternal hormones in the late stages of gestation. The onset of left heart failure results in decreased cardiac output, leading to insufficient perfusion, which in turn, contributes to pulmonary edema and exacerbates tissue hypoxia. This cardiovascular response activates the neurohumoral system, causing peripheral vasoconstriction and elevating both mean capillary filling pressure (MCFP) and central venous pressure (CVP). Early administration of furosemide reduces volume overload due to negative cumulative fluid balance gaining and vasodilation, which increases the velocity of intravascular refilling and causes interstitial edema to resolve. This will decrease interstitial fluid pressure, resulting in decreased mechanical compression to systemic capillary and systemic vein pressure, thus decreasing MCFP and CVP subsequently. Reduced CVP also contributes to increased venous return by decreasing the gradient pressure between MCFP and CVP, resulting in increased cardiac output (CO) and improved tissue oxygenation.

Case

A 33-year-old Asian woman, para 3 at full term pregnancy, admitted to the intensive care unit (ICU) after c-section and tubectomy due to shortness of breath and palpitation. Based on history taking, physical examination and echocardiography the patient fulfilled the criteria of PPCM which was also complicated by pulmonary edema. Despite impending respiratory failure, the patient rejected intubation and continuous positive airway pressure (CPAP), and was given oxygen supplementation through nasal cannula. Furosemide was given rapidly continued by maintenance dose and CVP was monitored. Antihypertensive drug, anticoagulants, and bromocriptine were also administered. After achieving negative cumulative fluid balance the patient’s symptoms resolved and was discharged one week later.

Conclusion

There is a correlation between negative cumulative fluid balance and reduced central venous pressure after early furosemide therapy. Suspicion for PPCM should not be lowered in the presence of preeclampsia, it could delay appropriate treatment and increase the mortality.
Literature
1.
go back to reference Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.CrossRefPubMed Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.CrossRefPubMed
2.
go back to reference Pearson GD, Velle JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institute of Health) workshop recommendation and review. JAMA. 2000;283:1183–8.CrossRefPubMed Pearson GD, Velle JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institute of Health) workshop recommendation and review. JAMA. 2000;283:1183–8.CrossRefPubMed
3.
go back to reference Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94:311–6.PubMed Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94:311–6.PubMed
4.
go back to reference Elkayam U, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. University of Southern California Keck School of Medicine. 2005; http://www.circulationaha.org. Elkayam U, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. University of Southern California Keck School of Medicine. 2005; http://​www.​circulationaha.​org.
7.
8.
9.
go back to reference Figueroa M, Peters JI. Congestive heart failure: diagnosis, pathophysiology, therapy, and implications of respiratory care. Respir Care. 2006;51(4):403–12.PubMed Figueroa M, Peters JI. Congestive heart failure: diagnosis, pathophysiology, therapy, and implications of respiratory care. Respir Care. 2006;51(4):403–12.PubMed
11.
go back to reference Palazzuoli A, Ranuccio N. Heart failure: pathophysiology and clinical picture. Italy: University of Siena; 2010. Palazzuoli A, Ranuccio N. Heart failure: pathophysiology and clinical picture. Italy: University of Siena; 2010.
14.
go back to reference Funk DJ, Jacobsohn E, Kumar A. The role of venous return in critical illness and shock—part I: physiology. Crit Care Med. 2013;41:255–62.CrossRefPubMed Funk DJ, Jacobsohn E, Kumar A. The role of venous return in critical illness and shock—part I: physiology. Crit Care Med. 2013;41:255–62.CrossRefPubMed
15.
go back to reference Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof of concept pilot study. Circulation. 2010;121:1465–73.CrossRefPubMed Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof of concept pilot study. Circulation. 2010;121:1465–73.CrossRefPubMed
16.
go back to reference Mullens W, et al. The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;21:137–55.CrossRef Mullens W, et al. The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;21:137–55.CrossRef
Metadata
Title
Guyton perspective in managing peripartum cardiomyopathy patient with pulmonary edema: a case report
Authors
Ruth Evlin Margaretha
Yohanes W. H. George
Jefferson Hidayat
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04398-2

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue